Edition:
India

Manojna Maddipatla

Anthem sees higher costs, persisting uncertainty due to COVID-19; shares dip

28 Oct 2020

U.S. health insurer Anthem Inc on Wednesday warned of higher-than-normal medical costs in the fourth quarter, driven by coronavirus infections and recovery in demand for elective medical procedures, sending its shares down about 3%.

UPDATE 3-Anthem sees higher costs, persisting uncertainty due to COVID-19; shares dip

28 Oct 2020

Oct 28 U.S. health insurer Anthem Inc on Wednesday warned of higher-than-normal medical costs in the fourth quarter, driven by coronavirus infections and recovery in demand for elective medical procedures, sending its shares down about 3%.

Merck says early data from COVID-19 vaccines expected this year

27 Oct 2020

Merck & Co Inc on Tuesday said it expects to report results from early-stage studies of two potential COVID-19 vaccines before the end of the year and has advanced an experimental antiviral drug into late-stage testing.

Abbott says COVID-19 test demand to grow in 2021

21 Oct 2020

Abbott Laboratories said it expects demand for its COVID-19 tests to grow in 2021 even if a vaccine is developed and for the business to eventually stabilize into a lucrative new franchise.

UPDATE 3-Abbott says COVID-19 test demand to grow in 2021

21 Oct 2020

Oct 21 Abbott Laboratories said it expects demand for its COVID-19 tests to grow in 2021 even if a vaccine is developed and for the business to eventually stabilize into a lucrative new franchise.

UPDATE 3-UnitedHealth approaches 2021 cautiously on COVID-19 uncertainty, shares fall

14 Oct 2020

Oct 14 UnitedHealth Group Inc on Wednesday took a conservative stance toward its expectations for 2021, citing uncertainties related to the COVID-19 pandemic, but raised its profit forecast for this year after third-quarter earnings beat estimates.

UPDATE 1-Nevada's ban on Quidel and Becton Dickinson COVID-19 tests violates law -HHS official

10 Oct 2020

Oct 9 Nevada's recent ban on the use of Quidel Corp's Sofia and Becton Dickinson and Co's Veritor point-of-care antigen tests for COVID-19 in long-term care facilities violates federal law, a U.S. government official said on Friday.

Abbott says new data shows rapid COVID-19 test used at White House is highly accurate

07 Oct 2020

Abbott Laboratories on Wednesday released early data from a study on the accuracy of its ID NOW COVID-19 test, which is used in the White House, that could help alleviate concerns the diagnostic frequently fails to detect the virus.

Bristol Myers expands heart drug business with $13 billion deal for MyoKardia

05 Oct 2020

Bristol Myers Squibb Co said on Monday it would buy MyoKardia Inc for about $13 billion to bolster its portfolio of heart disease treatments, ahead of the potential loss of sales exclusivity of some of its blockbuster drugs.

U.S. health agency sets October 16 deadline for states to submit vaccine plans

23 Sep 2020

The U.S. Centers for Disease Control and Prevention (CDC) on Tuesday set an Oct. 16 deadline for states to submit plans for distributing COVID-19 vaccines - even before it becomes clear when any will be available - according to a presentation to a panel of experts who make recommendations on U.S. vaccines.

World News